home / stock / nvo / nvo articles

NVO Articles, Novo Nordisk A/S - From 05/24/24

Stock Information
Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Menu
NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk Releases Data Showing Ozempic For Diabetes Slows Kidney Disease Progression | Benzinga

Novo Nordisk A/S’s (NYSE:NVO) shared data Friday on its kidney outcomes trial, FLOW. The trial evaluated once-weekly injectable Ozempic fo...
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review | Benzinga

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to meet on May 24 to review Novo Nordisk A/S...

Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns | Benzinga

Australia announced on Wednesday that it would ban compounded versions of weight-loss drugs like Novo Nordisk A/S’s (NYSE...

NeuroBo Pharmaceuticals Stock Slides Despite Animal Study Showing Wegvoy, Liver Fibrosis Success | Benzinga

NeuroBo Pharmaceuticals Inc (NASDAQ:NRBO) shares were down more than 6% at last check Wednesday. The Boston-based company announced preclinical da...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan | Benzinga

The Structure Therapeutics (NASDAQ:GPCR) stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a...

Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You | Benzinga

On Tuesday, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss ...

Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide | Benzinga

On Tuesday, Eli Lilly And Company (NYSE:LLY) announced that Chinese regulators have approved its diabetes drug tirzepatide.  This ap...
Wellness Platform Hims & Hers Health Adds GLP-1 Injections For Weight Loss, Stock Soars | Benzinga

On Monday, the health and wellness platform Hims & Hers Health Inc (NYSE:HIMS) shares traded higher after the company announced the a...

Genetic Profile Key To Novo Nordisk's Wegovy's Weight-Loss Effectiveness, Study Reveals | Benzinga

Researchers highlighted on Monday that certain genes may help identify patients with obesity who are most likely to respond strongly to&n...

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly | Benzinga

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its obesity drug Wegovy in 2021...
Previous 10 Next 10